ProPhase Labs to Present at the Access to Giving Virtual Investor Conference on July 15, 2021 GARDEN CITY, NY, July 12, 2021 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (Nasdaq: PRPH) (“ProPhase” or the “Company”), a diversified medical science and technology company, today announced that Chief...

ProPhase Labs to Present at the Virtual Fall Investor Summit on Monday, November 16, 2020 at 2:30 p.m. Eastern Time DOYLESTOWN, PA , Nov. 10, 2020 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH) (“ProPhase Labs”), a diversified medical science and technology company, today announced that management will...

ProPhase Announces Change in Tax Treatment of 2018 Dividends DOYLESTOWN, Pennsylvania, April 09, 2019 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH, www.ProPhaseLabs.com) announced a change in the reporting of dividends paid to its stockholders in...

ProPhase Labs Reports Financial Results for the Three Months and Nine Months Ended September 30, 2018 DOYLESTOWN, Pennsylvania, Nov. 14, 2018 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH, www.ProPhaseLabs.com) today reported its financial results for the three and nine months ended...

PROPHASE LABS, INC. ANNOUNCES SPECIAL CASH DIVIDEND DOYLESTOWN, PA, May 07, 2018 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH, www.ProPhaseLabs.com), a vertically integrated and diversified branding, marketing and technology company with...